Comparing Abreva vs Lysine
Abreva (docosanol) | Lysine |
|
---|
Abreva (docosanol) | Lysine |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Over-the-counter
Prescribed for Herpes Simplex (HSV). Abreva may also be used for purposes not listed in this medication guide. |
Over-the-counter
Used for Herpes Simplex - Suppression, Herpes Simplex (HSV), Aphthous Ulcer, Herbal Supplementation. Lysine may also be used for purposes not listed in this medication guide. |
Related suggestions Herpes Simplex (HSV)
Popular comparisons
|
|||||||
More about Abreva (docosanol) | More about Lysine | ||||||||
Ratings & Reviews | |||||||||
Abreva has an average rating of 4.5 out of 10 from a total of 426 ratings on Drugs.com. 36% of reviewers reported a positive effect, while 56% reported a negative effect. |
Lysine has an average rating of 8.9 out of 10 from a total of 118 ratings on Drugs.com. 86% of reviewers reported a positive effect, while 6% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Abreva side effects |
View all Lysine side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all Abreva prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | |||||||||
|
N/A |
||||||||
Brand Names | |||||||||
N/A |
L-Formula, L-Lysine | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
N/A |
N/A |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category N
Not classified
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
|
||||||||
Drug Interactions | |||||||||
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | |||||||||
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
First Approval Date | |||||||||
July 25, 2000 |
N/A |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.